Article
Version 1
Preserved in Portico This version is not peer-reviewed
New Pharmaceutical Salts of Trazodone
Version 1
: Received: 23 December 2020 / Approved: 23 December 2020 / Online: 23 December 2020 (13:42:36 CET)
A peer-reviewed article of this Preprint also exists.
Jaśkowska, J.; Zaręba, P.; Drabczyk, A.; Kozak, A.; Madura, I.D.; Majka, Z.; Pindelska, E. New Pharmaceutical Salts of Trazodone. Molecules 2021, 26, 769. Jaśkowska, J.; Zaręba, P.; Drabczyk, A.; Kozak, A.; Madura, I.D.; Majka, Z.; Pindelska, E. New Pharmaceutical Salts of Trazodone. Molecules 2021, 26, 769.
Abstract
New pharmaceutically acceptable salts of trazodone for the treatment of central nervous system disorders are synthesized and described. Each salt (trazodone hydrogen bromide and trazodone 1-hydroxy-2-naphthoate) was obtained by two or three different methods leading to the same crystalline form. Although trazodone salts are poorly crystalline, single-crystal X-ray diffraction data for trazodone 1-hydroxy-2-naphthoate were collected and analyzed as well as compared to the previously described crystal structure of commercially available trazodone hydrochloride. The powder samples of all new salts were characterized by Fourier transform infrared spectroscopy and 13C solid-state nuclear magnetic resonance spectroscopy. Spectroscopic studies were supported by gauge including projector augmented wave (GIPAW) calculations of carbon chemical shielding constants. The main goal of our research was to find salts with better physicochemical properties and to make an attempt to associate them with both the anion structure and the most prominent interactions exhibited by the protonated trazodone cation. The dissolution profiles of trazodone from tablets prepared from various salts with lactose monohydrate were investigated. The studies revealed that salts with simple anions show a fast release of the drug while the presence of more complex anion, more strongly interacting with the cation, effects a slow-release profile of the active substance and can be used for the preparation of the tables with a delay or prolonged mode of action.
Keywords
Trazodone; drug design; dissolution; crystal structure; solid-state NMR (SSNMR) spectroscopy; GIPAW calculation
Subject
Chemistry and Materials Science, Medicinal Chemistry
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment